Macrogen Spins Off Axeq Technologies for Next-Gen Sequencing Services | GenomeWeb

By Julia Karow

Seeking to raise its profile as a global provider of next-generation sequencing services, Korea's Macrogen has spun off a US-based division, Axeq Technologies.

Axeq, which started operating in January, offers a wide variety of sequencing services worldwide, including exome sequencing, whole-genome sequencing, targeted sequencing, pooled sequencing, RNA sequencing, ChIP sequencing, and Sanger sequencing, along with data-analysis services.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.